Amber List
CRSP
CRISPR Therapeutics AG
Healthcare · Biotechnology · mid-cap ($4.5B)
-35.7%
from rolling 252-day high of $78.48 set 2025-10-08 · 218d ago
Current
$50.45
Decline depth
-35.7%
Decline σ
3.6σ
TFC
4/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Structural break signals

CRSP qualifies for the Amber List on decline depth.

Decline depth
-35.7%
From rolling 252-day high of $78.48, 218d ago. Past the 30% Amber threshold.
Time-frame continuity
4/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 4/5 Amber threshold.
Decline sigma
3.6σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (4.16% per day).

The structural read

What price action says about CRSP.

CRSP qualifies for the Amber List on decline depth — down -35.7% from its rolling 252-day high.

Cross-confirmation: also showing 4/5 bearish time frames.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2U (red), monthly 1 (red).

52-week range

52W low $30.04 42.1% of range 52W high $78.48

Sector context · Healthcare

182 other Healthcare tickers are on Broken Stocks.

93 Red List
42 Amber
47 Watch
-35.8% Median decline

Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →

Questions about CRSP

What people ask.

Why is CRSP on Broken Stocks?

CRSP qualifies for the Amber List on decline depth. It is down -35.7% from its rolling 252-day high of $78.48, set on 2025-10-08 — 218d ago.

Is CRSP a falling knife?

Not by the strict technical definition. CRSP is down -35.7% from its 52-week high, but that high was set 218d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. CRSP is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.

Is CRSP a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is CRSP trading inside its 52-week range?

At $50.45, CRSP sits 42.1% of the way from its 52-week low ($30.04) to its 52-week high ($78.48). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has CRSP been declining?

The current 35.7% decline accrued over 218d, which annualizes to roughly -59.8% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does CRSP compare to its sector?

There are 182 other Healthcare tickers on Broken Stocks: 93 Red, 42 Amber, 47 Watch, with 55 showing recovering structural signals. Median sector decline is -35.8% — CRSP's decline is shallower than the sector median.